Medicine, a high-energy consumer and generator of much waste—some of it toxic—must scale back the health care enterprise in the interest of preserving a livable environment.
Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly.